2 - TI Pharma

Chapter 2 Glucocorticoids: metabolic side effects
16. Rosen j, Miner jN. The search for safer glucocorticoid receptor ligands. Endocr Rev. 2005;26(3):452-
42
64.
17. Schacke H, Rehwinkel H, Asadullah K, Cato AC. Insight into the molecular mechanisms of
glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic
index. Exp Dermatol. 2006;15(8):565-73.
18. Walker BR. Glucocorticoids and cardiovascular disease. Eur j Endocrinol. 2007;157(5):545-59.
19. DeFronzo RA, jacot E, jequier E, Maeder E, Wahren j, Felber jP. The effect of insulin on the disposal
of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous
catheterization. Diabetes. 1981;30(12):1000-7.
20. Henriksen jE, Alford F, Ward GM, Beck-Nielsen H. Risk and mechanism of dexamethasone-induced
deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.
Diabetologia. 1997;40(12):1439-48.
21. Rizza RA, Mandarino Lj, Gerich jE. Cortisol-induced insulin resistance in man: impaired suppression
of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin
action. j Clin Endocrinol Metab. 1982;54(1):131-8.
22. Krebs M, Krssak M, Bernroider E, Anderwald C, Brehm A, Meyerspeer M, Nowotny P, Roth E,
Waldhausl W, Roden M. Mechanism of amino acid-induced skeletal muscle insulin resistance in
humans. Diabetes. 2002;51(3):599-605.
23. Elks ML. Fat oxidation and diabetes of obesity: the Randle hypothesis revisited. Med Hypotheses.
1990;33(4):257-60.
24. Perseghin G, Petersen K, Shulman GI. Cellular mechanism of insulin resistance: potential links with
inflammation. Int J Obes Relat Metab Disord. 2003;27 Suppl 3:S6-11.
25. Ewart HS, Somwar R, Klip A. Dexamethasone stimulates the expression of GLUT1 and GLUT4
proteins via different signaling pathways in L6 skeletal muscle cells. FEBS Lett. 1998;421(2):120-4.
26. Long W, Barrett Ej, Wei L, Liu Z. Adrenalectomy enhances the insulin sensitivity of muscle protein
synthesis. Am j Physiol Endocrinol Metab 2003;284(1):E102-9.
27. Ruzzin j, Wagman AS, jensen j. Glucocorticoid-induced insulin resistance in skeletal muscles: defects
in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia.
2005;48(10):2119-30.
28. Saad Mj, Folli F, Kahn jA, Kahn CR. Modulation of insulin receptor, insulin receptor substrate-1,
and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. j Clin Invest.
1993;92(4):2065-72.
29. Weinstein SP, Wilson CM, Pritsker A, Cushman SW. Dexamethasone inhibits insulin-stimulated
recruitment of GLUT4 to the cell surface in rat skeletal muscle. Metabolism. 1998;47(1):3-6.
30. Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P et al. An in vivo and in vitro
study of the mechanism of prednisone-induced insulin resistance in healthy subjects. j Clin Invest.
1983;72(5):1814-20.